In stock
ADRIXA 4MG/ML 2ML AMPOULE 5 PCS
In stock
Only 1 left
SKU
10331011223
Adrixa 4mg/ml solution for injection is an effective antiemetic used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. Each pack contains 5 ampoules, providing rapid relief and improving patient comfort. This prescription-only medication contains Ondansetron as its active ingredient.
Product Overview
Adrixa 4mg/ml solution for injection, containing Ondansetron, is a potent antiemetic indicated for the prevention and treatment of nausea and vomiting. It is primarily used in patients undergoing chemotherapy or radiotherapy and for post-operative nausea and vomiting. This medication is essential for managing severe emesis, improving patient comfort and recovery. Each package contains 5 ampoules, with each 2ml ampoule providing a precise dose for intravenous administration.
Benefits of Use
- Effective prevention and treatment of chemotherapy-induced nausea and vomiting.
- Reliable management of radiotherapy-induced nausea and vomiting.
- Proven efficacy in controlling post-operative nausea and vomiting.
- Rapid onset of action when administered intravenously, providing quick relief.
- Supports patient well-being and improves quality of life during challenging medical treatments.
How to Use
- Adrixa 4mg/ml solution for injection must be administered by a qualified healthcare professional.
- The dosage and administration route (intravenous or intramuscular) will be determined by the physician based on the patient's condition, age, and the specific emetogenic potential of the therapy.
- For chemotherapy-induced nausea and vomiting, the usual adult dose is 8 mg administered as a slow intravenous injection immediately before treatment, followed by further doses as prescribed.
- For post-operative nausea and vomiting, a single 4 mg dose may be administered intravenously or intramuscularly at induction of anesthesia or shortly thereafter.
- Refer to the complete prescribing information for detailed dosing recommendations for specific indications and patient populations.
Caution & Warnings
- Adrixa should not be used in patients with known hypersensitivity to Ondansetron or any of its components.
- Use with caution in patients with signs of subacute intestinal obstruction, as Ondansetron may mask progressive ileus.
- Prolongation of QT interval has been observed with Ondansetron; use with caution in patients with risk factors for QT prolongation.
- Monitor for signs of serotonin syndrome if used concomitantly with serotonergic drugs.
- Pregnant or breastfeeding women should consult their doctor before use.
- Keep out of reach of children.
- Do not use if the solution is discolored or contains particulate matter.
Ingredients
Active Ingredient: Ondansetron (as Ondansetron Hydrochloride Dihydrate) 4 mg/ml.
Excipients: Sodium Chloride, Citric Acid Monohydrate, Sodium Citrate Dihydrate, Water for Injections.
Product Details
Form: Solution for Injection
Strength: 4 mg/ml
Package Size: 5 x 2 ml Ampoules
Manufacturer: Takeda
| Gtin | 805222002 |
|---|---|
| Recommended Sale Price | 27 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| SFDA Reg. No | 805222002 |
| IBC | 805222002 |
| Drug Type | Prescription |
| Scientific Name | Ondansetron Hydrochloride Dihydrate |
| Strength | 4MG/ML |
| Strength Unit | MG/ML |
| Form | Solution for Injection |
| Admin Route | Intravenous |
| Size | 2 |
| Size Unit | ML |
| Package Types | Ampoule |
| Package Size | 5 Ampoules |
| Storage conditions | Store below 30°C. Protect from light. |
| Refrigerator Storage | No |
| Distribute area | Saudi Arabia, Egypt |
Products you might like
